Suppression of tumour necrosis factor-alpha expression in leprosy skin lesions during treatment for leprosy

Br J Dermatol. 1997 Mar;136(3):393-7.

Abstract

The expression of tumour necrosis factor (TNF)-alpha in leprosy skin lesions was examined before and during successful treatment in a patient with borderline lepromatous leprosy. Before treatment, immunohistochemical staining of a skin biopsy specimen showed diffuse TNF-alpha deposits in granulomas and significant TNF-alpha deposits on infiltrated mononuclear cells. After 1 year's treatment, the skin lesions exhibited a reduction in granulomas, and a concomitant reduction in deposits of TNF-alpha. Furthermore, the level of expression of TNF-alpha messenger RNA, as examined using a reverse transcriptase-polymerase chain reaction method, was reduced markedly after treatment. These findings provide evidence for a correlation between the expression of TNF-alpha and disease activity suggesting that TNF-alpha is a useful prognostic indicator for inflammation in leprosy.

Publication types

  • Case Reports

MeSH terms

  • Aged
  • Anti-Infective Agents / therapeutic use
  • Gene Expression
  • Humans
  • Immunohistochemistry
  • Leprosy, Lepromatous / drug therapy
  • Leprosy, Lepromatous / metabolism*
  • Male
  • Ofloxacin / therapeutic use
  • Polymerase Chain Reaction
  • Skin / metabolism*
  • Tumor Necrosis Factor-alpha / analysis
  • Tumor Necrosis Factor-alpha / genetics
  • Tumor Necrosis Factor-alpha / metabolism*

Substances

  • Anti-Infective Agents
  • Tumor Necrosis Factor-alpha
  • Ofloxacin